Funding for this research was provided by:
National Outstanding Youth Science Fund Project of National Natural Science Foundation of China (82125007)
Natural Science Foundation of Beijing Municipality (Z200014)
Article History
Received: 11 April 2023
Accepted: 28 November 2023
First Online: 5 December 2023
Declarations
:
: This study involving human embryonic stem cell and its gene editing was approved by the Ethics Committee of Beijing Tongren Hospital, Capital Medical University (guidelines of the Declaration of Helsinki). Title of the approved project: Development of in vitro disease models for hereditary eye diseases. Approval number: TREC2021-088; Date of approval: Apr 22, 2021.
: Not applicable.
: The authors declare no competing interests.